Emerging Trends Archives - Page 3 of 3 - Deallus Strategic Intelligence Consultancy

Antimicrobial Resistance

White Paper

Antimicrobial Resistance

admin2021-05-12T11:56:09+01:00White Paper|

Lack of innovation surrounding the development of new antibiotics has resulted in an alarming situation, given the rising threat of antimicrobial resistance (AMR). As a result, there is no single or straightforward way to combat AMR, nor to galvanize development of novel antibiotics. Although some positive measures have been introduced, further - and larger scale - action is needed. We take a look at what pharma and the larger healthcare industry needs to do in order to combat this looming threat.

Copay Accumulator Programs & Pharma

White Paper

Copay Accumulator Programs & Pharma

admin2021-05-12T11:56:49+01:00White Paper|

Dynamics between pharma and the market-based healthcare sector it serves have invariably been complex, with one of the biggest drivers of that complexity being effective management of patient demand and payer systems. The newest stratagem in this push and pull is the copay accumulator program, or CAP. We take a closer look at CAPs and how they might affect your brand in the near future.

Competitive Intelligence in an Agile World

White Paper

Competitive Intelligence in an Agile World

admin2019-11-08T14:34:37+00:00White Paper|

Adapting competitive intelligence functions to an increasingly complex pharma landscape. This White Paper explores the concept of agile working for the pharma world, delving into the opportunities and challenges that arise for Competitive Intelligence teams and managers as working environments adapt to find success in a more dynamic, uncertain, and fast-paced environment.

Asia Market Entry

White Paper

Asia Market Entry

admin2020-06-22T08:14:43+01:00White Paper|

A continent of extremes, with great potential for growth. Geographically large, the assortment of cultures, people, disease profiles, and healthcare systems added to the juxtaposition of extreme wealth and extreme poverty, emphasises the many challenges faced by the pharmaceutical companies when thinking of entering Asia. Commercial success will depend on understanding the market dynamics by consolidating positioning within the market place with the requirements of each market.

Asian Pricing and Reimbursement

White Paper

Asian Pricing and Reimbursement

admin2020-02-12T10:28:49+00:00White Paper|

Growing major trends are emerging across Asian healthcare markets. Rising incomes, increased government healthcare expenditure, higher life expectancies and a surge of chronic illnesses are boosting the demand for pharmaceutical products and services in the region. We take a look at the emerging trends across Asian healthcare systems and the implications for the industry.